Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.
about
Nerve growth factor inhibits metalloproteinase-disintegrins and blocks ectodomain shedding of platelet glycoprotein VIArtificial neural networks allow the use of simultaneous measurements of Alzheimer disease markers for early detection of the disease.Platelets and Alzheimer's disease: Potential of APP as a biomarkerAlzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and GammaRole of platelets in neuroinflammation: a wide-angle perspectiveDecreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset.The role of proteomics in dementia and Alzheimer's disease.A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotypePlatelets, a reliable source for peripheral Alzheimer's disease biomarkers?Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease.Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's diseasePlatelet dysfunction in hypercholesterolemia mice, two Alzheimer's disease mouse models and in human patients with Alzheimer's disease.Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APPBACE1 as a potential biomarker for Alzheimer's diseaseMeasurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCRPeripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseasesADAM10 expression and promoter haplotype in Alzheimer's disease.Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease.Brain ischemia activates β- and γ-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer's disease.Alzheimer disease and platelets: how's that relevant.The amyloid cascade: the old and the new.Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal StudyOvariectomy increases neuronal amyloid-beta binding alcohol dehydrogenase level in the mouse hippocampus.Interactions between APP secretases and inflammatory mediators.Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease.Can platelet BACE1 levels be used as a biomarker for Alzheimer's disease? Proof-of-concept study.Plasma beta-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease.The development of effective biomarkers for Alzheimer's disease: a review.Nardilysin in human brain diseases: both friend and foe.Protein-based biomarkers in cerebrospinal fluid and blood for Alzheimer's disease.Mechanisms of Melatonin in Alleviating Alzheimer's Disease.Increase of α-Secretase ADAM10 in Platelets Along Cognitively Healthy Aging.The Distinction of Amyloid-β Protein Precursor (AβPP) Ratio in Platelet Between Alzheimer's Disease Patients and Controls: A Systematic Review and Meta-Analysis.Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases.Soluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road ahead.Variation in RTN3 and PPIL2 genes does not influence platelet membrane beta-secretase activity or susceptibility to alzheimer's disease in the northern Irish population.ADAM10 as a biomarker for Alzheimer's disease: a study with Brazilian elderly.Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI).Platelet alpha- and beta-secretase activities: A preliminary study in normal human subjects.
P2860
Q24299819-7DB2DA7C-F752-48E0-978F-D38C2FD4FB99Q24811064-2C8BB847-E01F-4E49-969E-407F388782BFQ27001550-DB40E96E-5F37-4637-8317-A4458A92B26BQ28075617-40A6C06F-8995-4FD7-8638-1E62CB711C16Q28393808-3B96508B-553C-4AFF-9EC3-8C9613653C96Q30887981-4F2B21D8-D5C6-46AF-91EE-A6C0EAD80E99Q33414691-60CACC44-80D5-42FA-B185-5DA61A920051Q34363475-585B823D-0E7D-4A72-A0BA-3B544C458E25Q34500658-B9C125FD-0038-4A9D-BDCE-2039B869E668Q34680488-54FA8313-F387-4A71-AA27-2C2D1254164BQ34824216-19FBAC24-2CD4-472E-BEB0-F30EA26E2081Q35141182-09700302-B30B-4E64-809B-F0A82D02EA15Q35804607-F7C03943-C524-4E99-975C-5314BF78BF04Q35845926-8819475D-71AD-4031-97AF-90D44CD68E55Q35856328-CAB82368-19E1-4D22-AA41-F817748DD7E8Q35886927-C6862574-1969-4F56-91F8-53C1CB0710A0Q36023238-140EFF7B-437D-45C5-B728-9217BF472F89Q36080855-74EDE73D-17AA-45C3-8E48-6A0D28E8E3EBQ36300032-9E3E4B11-4A74-4945-AA1F-A7E0A49123CDQ36511844-4F928EB1-5678-4C3B-B6F8-9A8326AF3535Q36535484-B97AEF6F-2974-41D1-83BE-CDFD0760FB7CQ37047842-5FF6E92E-2F9F-4DAD-A181-506AC80C643EQ37053743-1025980A-C420-4F1B-918A-FA032BB3E1F9Q37070169-1B0865DB-9B10-4654-81CA-00ACB5A28FF3Q37195010-C5267CC0-1A14-48A5-A334-7A7A1AD744BAQ37578319-BD09670B-0F2B-44B0-ABEF-7F9AAFB5EDBDQ37725038-6F9D7E2E-AEED-4C9F-802E-A47B0A58F991Q37766778-468E0E14-3A17-4BE6-A17E-213F944F9A29Q38016800-7C47EBD4-1052-4BD0-AE05-9EC06E02763DQ38100617-ADD7D655-2737-463D-AF8C-F891804366A3Q38222874-0B730640-AC50-4C85-8F69-7946C55B7D82Q39178920-1D92EECB-92E6-4912-AA7C-0A1AFF07B190Q39285908-81510104-7726-403C-A366-AC1C6D049A50Q39450376-34D01DF0-763E-4D14-8F71-D4E6E0078AD2Q40143775-87B3F195-BDB7-4D59-B6F4-3DC3CF78F7CDQ43244936-E5CE262D-1C42-45E5-B17E-F1C0D0AB0E7FQ43294486-26B59D6B-9BA1-4C32-A1B8-0F0E9CEE0E07Q43857484-2D62363B-C46D-4204-B64B-AC3B35E7ADC7Q44257894-181B30B2-2ACE-4B63-8547-E2976FFFF4F5Q46145107-54A44078-E3A3-46E1-9E90-4594F4A6646E
P2860
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.
@en
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.
@nl
type
label
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.
@en
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.
@nl
prefLabel
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.
@en
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.
@nl
P2093
P1433
P1476
Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.
@en
P2093
A Padovani
C Caltagirone
E Marcello
F Cattabeni
F Colciaghi
P304
P356
10.1212/01.WNL.0000106953.49802.9C
P407
P577
2004-02-01T00:00:00Z